Radical prostatectomy versus watchful waiting in early prostate cancer

New England Journal of Medicine

Volumn 364, Issue 18, 2011, Pages 1708-1717

  Bill Axelson, Anna ^a,c,d   Holmberg, Lars ^b,k   Ruutu, Mirja ^k   Garmo, Hans ^b,j   Stark, Jennifer R ^a,m   Busch, Christer ^c   Nordling, Stig ^l   Häggman, Michael ^a   Andersson, Swen Olof ^a   Bratell, Stefan ^g   Spångberg, Anders ^h   Palmgren, Juni ^e   Steineck, Gunnar ^d,i   Adami, Hans Olov ^e,n   Johansson, Jan Erik ^a,f  

^a Department of Urology ^*  (Sweden)

^b Regional Oncologic Center   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Division of Clinical Cancer Epidemiology   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Centre for Assessment of Medical Technology   (Sweden)

^g BORÅS HOSPITAL   (Sweden)

^h LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k Departments of Urology   (United States)

^l HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIGITAL RECTAL EXAMINATION; EARLY CANCER; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMPOTENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; WATCHFUL WAITING; AGE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FOLLOW UP; INTENTION TO TREAT ANALYSIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATE; PROSTATE TUMOR; RISK; RISK FACTOR; SURVIVAL;

AGE FACTORS; AGED; FOLLOW-UP STUDIES; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK; RISK FACTORS; SURVIVAL ANALYSIS; WATCHFUL WAITING;

EID: 79955705831     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1011967     Document Type: Article

References (21)

1. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781-9. (Pubitemid 34988336)
2. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977-84. (Pubitemid 40638368)
3. Bill-Axelson A, Holmberg L, Filen F, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. J Natl Cancer Inst 2008; 100:1144-54.
4. Adami HO. The prostate cancer pseudoepidemic. Acta Oncol 2010;49:298-304.
5. Harmer MH, ed. TNM classification of malignant tumours. Geneva: International Union Against Cancer, 1978.
6. Brendler CB, Cleeve LK, Anderson EE, Paulson DF. Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol 1980;124:849-50. (Pubitemid 11210570)
7. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4: 473-85. (Pubitemid 14236144)
8. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. Philadelphia: Lea & Febiger, 1977.
9. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
10. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
11. Widmark A, Klepp O, Solberg A, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009;373: 301-8. [Erratum, Lancet 2009;373:1174.]
12. Wong YN, Mitra N, Hudes G, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006;296:2683-93. [Erratum, JAMA 2007;297:42.] (Pubitemid 44917546)
13. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am 2001;28: 555-65. (Pubitemid 32916759)
14. Eggener, SE, Scardino PT, Walsh PC, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011;185:869-75.
15. Rosenthal SA, Bae K, Pienta KJ, et al. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus longterm androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02. Int J Radiat Oncol Biol Phys 2009; 73:672-8.
16. Wiegel T, Bottke D, Steiner U, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009;27:2924-30.
17. Klotz LH, Nam RK. Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis. Can J Urol 2006;13:Suppl 1:48-55.
18. Donovan J, Hamdy F, Neal D, et al. Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 2003;7:1-88.
19. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126-31.
20. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347:790-6. (Pubitemid 34988337)
21. Johansson E, Bill-Axelson A, Holmberg L, Onel.v E, Johansson JE, Steineck G. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. Eur Urol 2009;55: 422-30.